TY - JOUR
T1 - Exonic re-sequencing of the chromosome 2q24.3 Parkinson's disease locus
AU - Labbé, Catherine
AU - Ogaki, Kotaro
AU - Lorenzo-Betancor, Oswaldo
AU - Carrasquillo, Minerva M.
AU - Heckman, Michael G.
AU - McCarthy, Allan
AU - Soto-Ortolaza, Alexandra I.
AU - Walton, Ronald L.
AU - Lynch, Timothy
AU - Siuda, Joanna
AU - Opala, Grzegorz
AU - Krygowska-Wajs, Anna
AU - Barcikowska, Maria
AU - Czyzewski, Krzysztof
AU - Dickson, Dennis W.
AU - Uitti, Ryan J.
AU - Wszolek, Zbigniew K.
AU - Ross, Owen A.
N1 - Funding Information:
We would like to thank all those who have contributed to our research, particularly the patients and families who donated DNA samples and brain tissue for this work. This work is supported by a Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50 #NS072187), NINDS R01 NS078086, Michael J. Fox Foundation, and a gift from Carl Edward Bolch, Jr., and Susan Bass Bolch. CL is the recipient of a FRSQ postdoctoral fellowship.
Publisher Copyright:
© 2015 Labbé et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2015/6/19
Y1 - 2015/6/19
N2 - Genome-wide association studies (GWAS) in Parkinson's disease (PD) have identified over 20 genomic regions associated with disease risk. Many of these loci include several candidate genes making it difficult to pinpoint the causal gene. The locus on chromosome 2q24.3 encompasses three genes: B3GALT1, STK39, and CERS6. In order to identify if the causal variants are simple missense changes, we sequenced all 31 exons of these three genes in 187 patients with PD. We identified 13 exonic variants including four non-synonymous and three insertion/deletion variants (indels). These non-synonymous variants and rs2102808, the GWAS tag SNP, were genotyped in three independent series consisting of a total of 1976 patients and 1596 controls. Our results show that the seven identified 2q24.3 coding variants are not independently responsible for the GWAS association signal at the locus; however, there is a haplotype, which contains both rs2102808 and a STK39 exon 1 6bp indel variant, that is significantly associated with PD risk (Odds Ratio [OR] = 1.35, 95% CI: 1.11-1.64, P = 0.003). This haplotype is more associated than each of the two variants independently (OR = 1.23, P = 0.005 and 1.10, P = 0.10, respectively). Our findings suggest that the risk variant is likely located in a non-coding region. Additional sequencing of the locus including promoter and regulatory regions will be needed to pinpoint the association at this locus that leads to an increased risk to PD.
AB - Genome-wide association studies (GWAS) in Parkinson's disease (PD) have identified over 20 genomic regions associated with disease risk. Many of these loci include several candidate genes making it difficult to pinpoint the causal gene. The locus on chromosome 2q24.3 encompasses three genes: B3GALT1, STK39, and CERS6. In order to identify if the causal variants are simple missense changes, we sequenced all 31 exons of these three genes in 187 patients with PD. We identified 13 exonic variants including four non-synonymous and three insertion/deletion variants (indels). These non-synonymous variants and rs2102808, the GWAS tag SNP, were genotyped in three independent series consisting of a total of 1976 patients and 1596 controls. Our results show that the seven identified 2q24.3 coding variants are not independently responsible for the GWAS association signal at the locus; however, there is a haplotype, which contains both rs2102808 and a STK39 exon 1 6bp indel variant, that is significantly associated with PD risk (Odds Ratio [OR] = 1.35, 95% CI: 1.11-1.64, P = 0.003). This haplotype is more associated than each of the two variants independently (OR = 1.23, P = 0.005 and 1.10, P = 0.10, respectively). Our findings suggest that the risk variant is likely located in a non-coding region. Additional sequencing of the locus including promoter and regulatory regions will be needed to pinpoint the association at this locus that leads to an increased risk to PD.
UR - http://www.scopus.com/inward/record.url?scp=84939178834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84939178834&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0128586
DO - 10.1371/journal.pone.0128586
M3 - Article
C2 - 26090850
AN - SCOPUS:84939178834
SN - 1932-6203
VL - 10
JO - PloS one
JF - PloS one
IS - 6
M1 - e0128586
ER -